- Report
- February 2018
- 680 Pages
Global
From €20914EUR$22,000USD£17,570GBP
- Report
- October 2024
- 90 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2023
- 94 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- March 2022
- 105 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- October 2023
- 101 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- August 2023
- 94 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- March 2022
- 101 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- August 2022
- 814 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- May 2022
- 97 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- January 2025
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- January 2025
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- January 2025
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- August 2024
- 285 Pages
China
From €3803EUR$4,000USD£3,195GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more